• Business Enquiry - enquiry@sthreechemicals.com
Linkedin
Contact Us

Trientine Tetrahydrochloride

Trientine Tetrahydrochloride

Trientine tetrahydrochloride (brand name Cuprior) was approved for medical use in the European Union in September 2017. It is indicated for the treatment of Wilson’s disease in adults, adolescents and children five years of age or older who are intolerant to D-penicillamine therapy.

Systematic Name

N'-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine;tetrahydrochloride

Brand Name(S)

Cuvrior

Therapeutic Category

Wilson's disease

Suitable Formulations

Solid

Approvals

US DMF

EU-WC

Do You Have A Question? Lets Have A Talk

Contact Us

Sthree Chemicals excels in pharmaceutical chemistry, offering quality, reliability, transparency, and trusted partnership for global pharmaceutical success.

Pages

Products

Get In Touch

Enquire now
© Copyright 2023. All Rights Reserved
Linkedin

Sthree chemicals is a pure-play API manufacturer with a diverse portfolio of capabilities in delivering efficiencies to generic players globally. Founded in 2012 by a team with vast experience across the pharmaceutical value chain, the company is on a mission to become the most preferred partner for pharmaceuticals.